Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  O'Mahony, Aoife M ^a   Ogier, Julien ^b   Darcy, Raphael ^b   Cryan, John F ^a   O'Driscoll, Caitriona M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; CYCLODEXTRIN; MACROGOL; SMALL INTERFERING RNA; SODIUM CHLORIDE; MACROGOL DERIVATIVE; POLYETHYLENE GLYCOL 1000;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; EMBRYO; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; LUCIFERASE REPORTER GENE; MOLECULAR SIZE; MOLECULAR STABILITY; MOUSE; NERVE CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REPORTER GENE; SERUM; SURFACE PROPERTY; ANIMAL; CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; METABOLISM; PROCEDURES;

ANIMALS; CELL LINE; CYCLODEXTRINS; DRUG DELIVERY SYSTEMS; GENE SILENCING; MICE; NEURONS; POLYETHYLENE GLYCOLS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84879266154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066413     Document Type: Article

References (50)

1. Guo J, Fisher KA, Darcy R, Cryan JF, O'Driscoll C, (2010) Therapeutic targeting in the silent era: advances in non-viral siRNA delivery. Mol BioSyst 6: 1143-1161.
2. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
3. Kim DH, Rossi JJ, (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genet 8: 173-184.
4. Rettig GR, Behlke MA, (2012) Progress Toward In Vivo Use of siRNAs-II. Mol Ther 20: 483-512.
5. Bumcrot D, Manoharan M, Koteliansky V, Sah DWY, (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2: 711-719.
6. Bergen JM, Park IK, Horner PJ, Pun SH, (2008) Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 25: 983-998.
7. Perez-Martinez FC, Guerra J, Posadas I, Cena V, (2011) Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System. Pharm Res 28: 1843-1858.
8. Mellet CO, Fernandez JMG, Benito JM, (2011) Cyclodextrin-based gene delivery systems. Chem Soc Rev 40: 1586-1608.
9. Méndez-Ardoy A, Urbiola K, Aranda C, Ortiz-Mellet C, García-Fernández JM, et al. (2011) Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery. Nanomedicine 6: 1697-1707.
10. O'Mahony AM, O'Neill MJ, Godinho BMDC, Darcy R, Cryan JF, et al. (2012) Cyclodextrins for Non-Viral Gene and siRNA Delivery. Pharm Nanotechnol 1: 6-14.
11. Cryan SA, Donohue R, Ravo BJ, Darcy R, O'Driscoll CM, (2004) Cationic cyclodextrin amphiphiles as gene delivery vectors. J Drug Del Sci Technol 14: 57-62.
12. McMahon A, Gomez E, Donohue R, Forde D, Darcy R, et al. (2008) Cyclodextrin gene vectors: cell trafficking and the influence of lipophilic chain length. J Drug Del Sci Technol 18: 303-307.
13. McMahon A, O'Neill MJ, Gomez E, Donohue R, Forde D, et al. (2012) Targeted gene delivery to hepatocytes with galactosylated amphiphilic cyclodextrins. J Pharm Pharmacol 64: 1063-1073.
14. O'Neill MJ, Guo J, Byrne C, Darcy R, O' Driscoll CM, (2011) Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells. Int J Pharm 413: 174-183.
15. Guo J, Ogier JR, Desgranges S, Darcy R, O Driscoll C, (2012) Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice. Biomaterials 33: 7775-7784.
16. O'Mahony AM, Ogier J, Desgranges S, Cryan JF, Darcy R, et al. (2012) A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery. Org Biomol Chem 10: 4954-4960.
17. O'Mahony AM, Godinho BMDC, Ogier J, Devocelle M, Darcy R, et al. (2012) Click-Modified Cyclodextrins as Nonviral Vectors for Neuronal siRNA Delivery. ACS Chem Neurosci 10: 744-752.
18. Godinho BMDC, Ogier J, Darcy R, O' Driscoll CM, Cryan JF, (2012) Self-assembling Modified β-Cyclodextrin Nanoparticles as Neuronal siRNA Delivery Vectors: Focus on Huntington's Disease. Mol Pharm 10: 640-649.
19. Kostarelos K, Miller AD, (2005) Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev 34: 970-994.
20. Beyerle A, Merkel O, Stoeger T, Kissel T, (2010) PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: Structure-function relationships. Toxicol Appl Pharmacol 242: 146-154.
21. Guo J, Cheng WP, Gu J, Ding C, Qu X, et al. (2012) Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice. Eur J Pharm Sci 45: 521-532.
22. Vader P, van der Aa LJ, Engbersen JFJ, Storm G, Schiffelers RM, (2012) Physicochemical and Biological Evaluation of siRNA Polyplexes Based on PEGylated Poly(amido amine)s. Pharm Res 29: 352-361.
23. Mendonca LS, Firmino F, Moreira JN, de Lima MCP, Simoes S, (2010) Transferrin Receptor-Targeted Liposomes Encapsulating anti-BCR-ABL siRNA or asODN for Chronic Myeloid Leukemia Treatment. Bioconjug Chem 21: 157-168.
24. Morille M, Passirani C, Dufort S, Bastiat G, Pitard B, et al. (2011) Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials 32: 2327-2333.
25. Kong W-H, Sung D-K, Shim Y-H, Bae KH, Dubois P, et al. (2009) Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation. J Controlled Release 138: 141-147.
26. Lee SH, Kim SH, Park TG, (2007) Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem Biophys Res Commun 357: 511-516.
27. Jung S, Lee SH, Mok H, Chung HJ, Park TG, (2010) Gene silencing efficiency of siRNA-PEG conjugates: Effect of PEGylation site and PEG molecular weight. J Controlled Release 144: 306-313.
28. Hong K, Zheng W, Baker A, Papahadjopoulos D, (1997) Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 400: 233-237.
29. Pun SH, Davis ME, (2002) Development of a nonviral gene delivery vehicle for systemic application. Bioconjug Chem 13: 630-639.
30. Ping Y, Liu C, Zhang Z, Liu KL, Chen J, et al. (2011) Chitosan-graft-(PEI-beta-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials 32: 8328-8341.
31. Davis ME, (2009) The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic. Mol Pharm 6: 659-668.
32. O'Mahony AM, Desgranges S, Ogier J, Quinlan A, Devocelle M, et al. (2012) In Vitro Investigations of the Efficacy of Cyclodextrin-siRNA Complexes Modified with Lipid-PEG-Octaarginine: Towards a Formulation Strategy for Non-viral Neuronal siRNA Delivery. Pharm Res 30: 1086-1098.
33. Donohue R, Mazzaglia A, Ravoo BJ, Darcy R (2002) Cationic beta-cyclodextrin bilayer vesicles. Chemical Communications: 2864-2865.
34. Bergen JM, Pun SH, (2008) Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons. J Gene Med 10: 187-197.
35. Tsutsumi T, Hirayama F, Uekama K, Arima H, (2008) Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA. J Pharm Sci 97: 3022-3034.
36. Cryan SA, Holohan A, Donohue R, Darcy R, O'Driscoll CM, (2004) Cell transfection with polycationic cyclodextrin vectors. Eur J Pharm Sci 21: 625-633.
37. Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AMF, et al. (2004) Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 145: 393-400.
38. O'Mahony AM, Doyle D, Darcy R, Cryan JF, O' Driscoll CM, (2012) Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications. Eur J Pharm Sci 47: 896-903.
39. Desigaux L, Sainlos M, Lambert O, Chevre R, Letrou-Bonneval E, et al. (2007) Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference. Proc Natl Acad Sci USA 104: 16534-16539.
40. Díaz-Moscoso A, Guilloteau N, Bienvenu C, Méndez-Ardoy A, Jiménez Blanco JL, et al. (2011) Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery. Biomaterials 32: 7263-7273.
41. Bartlett DW, Davis ME, (2007) Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug Chem 18: 456-468.
42. Ohki EC, Tilkins ML, Ciccarone VC, Price PJ, (2001) Improving the transfection efficiency of post-mitotic neurons. J Neurosci Methods 112: 95-99.
43. Davidson TJ, Harel S, Arboleda VA, Prunell GF, Shelanski ML, et al. (2004) Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J Neurosci 24: 10040-10046.
44. Krichevsky AM, Kosik KS, (2002) RNAi functions in cultured mammalian neurons. Proc Natl Acad Sci U S A 99: 11926-11929.
45. Lingor P, Michel U, Scholl U, Bahr M, Kugler S, (2004) Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons. Biochem Biophys Res Commun 315: 1126-1133.
46. Schäfer J, Höbel S, Bakowsky U, Aigner A, (2010) Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. Biomaterials 31: 6892-6900.
47. Mishra S, Webster P, Davis ME, (2004) PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol 83: 97.
48. Cardoso ALC, Costa P, de Almeida LP, Simoes S, Plesnila N, et al. (2010) Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo. J Controlled Release 142: 392-403.
49. Kumar P, Wu HQ, McBride JL, Jung KE, Kim MH, et al. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448: 39-U32.
50. Cheng TL, Wu PY, Wu MF, Chern JW, Roffler SR, (1999) Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM. Bioconjugate Chemistry 10: 520-528.